TRIM E3 ligases interfere with early and late stages of the retroviral life cycle
2008

TRIM E3 Ligases and Their Role in Retroviral Life Cycle

Sample size: 55 publication 10 minutes Evidence: high

Author Information

Author(s): Uchil Pradeep D, Quinlan Brian D, Chan Wai-Tsing, Luna Joseph M, Mothes Walther

Primary Institution: Yale University School of Medicine

Hypothesis

Several TRIM proteins may contribute to the innate immunity to retroviruses.

Conclusion

The study identifies multiple TRIM proteins that exhibit antiviral activities affecting both early and late stages of the retroviral life cycle.

Supporting Evidence

  • TRIM proteins were shown to inhibit HIV entry and enhance N-MLV entry.
  • Gene silencing of specific TRIM proteins affected viral release.
  • TRIM11 was found to regulate the levels of TRIM5, impacting retroviral restriction.

Takeaway

Scientists studied proteins called TRIMs to see how they help fight off viruses like HIV, and found that many of them can stop the virus from entering or leaving cells.

Methodology

The study involved screening 55 TRIM proteins for their ability to interfere with retroviral entry and release in HEK293 cells.

Potential Biases

Potential bias in the selection of TRIM proteins and the experimental conditions used.

Limitations

The study primarily focused on a limited number of TRIM proteins and their effects in a specific cell line.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.ppat.0040016

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication